tirzepatide w - Metabolic / GLP Tirzepatide - Weightloss Medicine

Worth a read for anyone following obesity care and real-world evidence: To view or add a comment, sign in A diagnostic paradox buried in the Lancet obesity framework: Patient A: HbA1c 6.1% + dyslipidemia meets definition of "clinical obesity" Patient B: HbA1c 6.8% (diagnosed T2DM) + normal lipids may not qualify as "clinical obesity" T2DM was excluded from the organ-dysfunction criteria despite: ~90% of T2DM patients being overweight or obese Strong mechanistic links to visceral & ectopic fat ~50% diabetes remission rate with intensive weight loss at 1 year This inconsistency may create real coverage and access problems

I ask for a replacement vial or a new label if the information stays unclear

This means it was synthetically designed to be highly selective

Tirzepatide Titration Schedule by Week Dosing follows a gradual increase to keep side effects manageable

Lys 16 Replacing the Gly 22 of GLP-1 with Ala or Aib slightly decreased both its affinity and activity (Ala IC 50 : 0.27 nM0.57 nM;EC 50 : 2.6 nM4 nM)